Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Suratadenoturev by Oncolys BioPharma for Adenocarcinoma Of The Gastroesophageal Junction: Likelihood of Approval
Suratadenoturev is under clinical development by Oncolys BioPharma and currently in Phase II for Adenocarcinoma Of The Gastroesophageal Junction. According...
Data Insights
Suratadenoturev by Oncolys BioPharma for Gastric Cancer: Likelihood of Approval
Suratadenoturev is under clinical development by Oncolys BioPharma and currently in Phase II for Gastric Cancer. According to GlobalData, Phase...